Cargando…

Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis

BACKGROUND & OBJECTIVES: Ischaemic heart disease (IHD) has been one of the leading causes of mortality in the world. In many European countries the mortality rates due to IHD have been rising rapidly. This study was aimed to assess the IHD mortality trend in Serbia. METHODS: A population-based c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilic, Milena, Ilic, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926346/
https://www.ncbi.nlm.nih.gov/pubmed/29664033
http://dx.doi.org/10.4103/ijmr.IJMR_1935_15
_version_ 1783318884842995712
author Ilic, Milena
Ilic, Irena
author_facet Ilic, Milena
Ilic, Irena
author_sort Ilic, Milena
collection PubMed
description BACKGROUND & OBJECTIVES: Ischaemic heart disease (IHD) has been one of the leading causes of mortality in the world. In many European countries the mortality rates due to IHD have been rising rapidly. This study was aimed to assess the IHD mortality trend in Serbia. METHODS: A population-based cross-sectional study analyzing IHD mortality in Serbia in the period 1991-2013 was carried out based on official data. The age-standardized rates (ASRs, per 100,000) were calculated using the direct method, according to the European standard population. Joinpoint analysis was used to estimate the average annual percentage change (AAPC) with the corresponding 95 per cent confidence interval (CI). RESULTS: More than 253,000 people (143,420 men and 110,276 women) died due to IHD in Serbia during the observed period, and most of them (over 160,000 people) were patients with myocardial infarction (MI). Average annual ASR for IHD was 113.6/100,000. There was no overall significant trend for mortality due to IHD (AAPC=+0.1%, 95% CI −0.8-1.0), but there was one joinpoint: the trend significantly increased by +2.3 per cent per year from 1991 to 2006 and then significantly decreased by −6.4 per cent from 2006 to onwards. Significantly decreased mortality trends for MI in both genders were observed: according to the comparability test, mortality trends in men and women were parallel (final selected model failed to reject parallelism, P=0.0567). INTERPRETATION & CONCLUSIONS: No significant trend for mortality due to IHD was observed in Serbia during the study period. The substantial decline of mortality from IHD seen in most developed countries during the past decades was not observed in Serbia. Further efforts are required to reduce mortality from IHD in Serbian population.
format Online
Article
Text
id pubmed-5926346
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59263462018-05-08 Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis Ilic, Milena Ilic, Irena Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Ischaemic heart disease (IHD) has been one of the leading causes of mortality in the world. In many European countries the mortality rates due to IHD have been rising rapidly. This study was aimed to assess the IHD mortality trend in Serbia. METHODS: A population-based cross-sectional study analyzing IHD mortality in Serbia in the period 1991-2013 was carried out based on official data. The age-standardized rates (ASRs, per 100,000) were calculated using the direct method, according to the European standard population. Joinpoint analysis was used to estimate the average annual percentage change (AAPC) with the corresponding 95 per cent confidence interval (CI). RESULTS: More than 253,000 people (143,420 men and 110,276 women) died due to IHD in Serbia during the observed period, and most of them (over 160,000 people) were patients with myocardial infarction (MI). Average annual ASR for IHD was 113.6/100,000. There was no overall significant trend for mortality due to IHD (AAPC=+0.1%, 95% CI −0.8-1.0), but there was one joinpoint: the trend significantly increased by +2.3 per cent per year from 1991 to 2006 and then significantly decreased by −6.4 per cent from 2006 to onwards. Significantly decreased mortality trends for MI in both genders were observed: according to the comparability test, mortality trends in men and women were parallel (final selected model failed to reject parallelism, P=0.0567). INTERPRETATION & CONCLUSIONS: No significant trend for mortality due to IHD was observed in Serbia during the study period. The substantial decline of mortality from IHD seen in most developed countries during the past decades was not observed in Serbia. Further efforts are required to reduce mortality from IHD in Serbian population. Medknow Publications & Media Pvt Ltd 2017-12 /pmc/articles/PMC5926346/ /pubmed/29664033 http://dx.doi.org/10.4103/ijmr.IJMR_1935_15 Text en Copyright: © 2017 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ilic, Milena
Ilic, Irena
Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title_full Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title_fullStr Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title_full_unstemmed Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title_short Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis
title_sort ischaemic heart disease mortality in serbia, 1991-2013; a joinpoint analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926346/
https://www.ncbi.nlm.nih.gov/pubmed/29664033
http://dx.doi.org/10.4103/ijmr.IJMR_1935_15
work_keys_str_mv AT ilicmilena ischaemicheartdiseasemortalityinserbia19912013ajoinpointanalysis
AT ilicirena ischaemicheartdiseasemortalityinserbia19912013ajoinpointanalysis